Comparing the SPTAN1 expression of all tumor tissues, we found a trend of reduced SPTAN1 expression in MLH1-deficient vs. MLH1-proficient tumors (p = 0.271) (Fig 2C). This evidence concerns the gene SPTAN1 and neoplasm.